期刊文献+

纳洛酮联合醒脑静对肝性脑病患者的治疗效果 被引量:3

The treatment effect of naloxone combined with Xingnaojing Injection on patients with hepatic encephalopathy
下载PDF
导出
摘要 目的:探讨纳洛酮和醒脑静注射液联合治疗肝性脑病的临床效果。方法:选择收治的肝性脑病患者58例,随机分为观察组和对照组,每组29例。两组均给予肝性脑病常规治疗,对照组同时给予纳洛酮治疗,观察组同时给予纳洛酮联合醒脑静注射液治疗。观察两组肝功能和血氨水平改变情况。结果:观察组治疗前肝功能(AST、ALT)和血氨水平和对照组治疗前肝功能和血氨水平比较,差异无统计学意义(P>0.05)。观察组治疗后肝功能和血氨水平分别和对照组治疗后比较,差异有统计学意义(P<0.05)。观察组总有效率(显效和有效所占比例)高于对照组,差异有统计学意义(P<0.05)。结论:纳洛酮联合醒脑静注射液能够显著降低肝性脑病患者血氨水平,改善功能,效果显著。 Objective To explore the clinical effect of naloxone and Xingnaojing Injection in treatment of hepatic encephalopathy. Method 58 patients with hepatic encephalopathy treated in our hospital were randomly divided into the observation group and the control group,with 29 cases in each group. The two groups were given conventional treatment of hepatic encephalopathy,while the control group received naloxone treatment,the observation group was given naloxone combined with Xingnaojing injection treatment. The changes of liver function and blood ammonia level were observed in the two groups. Results There was no significant difference in liver function(AST,ALT) and blood ammonia level between the observation group and the control group before treatment(P〈0. 05). After treatment,the liver function and the level of blood ammonia in the observation group were compared with the control group,and the difference was statistically significant(P〈0. 05). The total effective rate(significant and effective proportion) of the observation group was higher than that of the control group,and the difference was statistically significant(P〈0. 05). Conclusion Naloxone combined with Xingnaojing injection can significantly reduce the level of blood ammonia in patients with hepatic encephalopathy,and improve function,The effect is remarkable.
作者 申友平 SHEN You -ping(The People's Hospital of Leye County,Baise 533200, Chin)
出处 《吉林医学》 CAS 2018年第5期825-826,共2页 Jilin Medical Journal
关键词 肝性脑病 纳洛酮 醒脑静注射液 肝功能 血氨 Hepatic encephalopathy Naloxone Xingnaojing injection Liver function Blood ammonia
  • 相关文献

参考文献5

二级参考文献62

  • 1邢卉春.肝性脑病诊断治疗专家共识[J].中国肝脏病杂志(电子版),2009,1(2):46-55. 被引量:39
  • 2刘建生,傅极,张晓红,吴云林.肝性脑病血苯二氮和β-内啡肽变化及纳络酮治疗作用[J].医师进修杂志,2004,27(9):26-27. 被引量:12
  • 3陈晓辉,许松青,刘芳,江慧琳,林佩仪,熊旭明,李昭骥,陈敏生.纳洛酮对心肺复苏犬脑组织S100蛋白表达的影响[J].中华急诊医学杂志,2004,13(8):529-531. 被引量:13
  • 4Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia[J]. Metab Brain Dis, 2002, 17: 221-227.
  • 5Riordan SM, Williams R. Treatment of hepatic encephalopathy[J]. N Engl J Med, 1997, 337: 473-479.
  • 6Dadsetan S, Kukolj E, Bak LK, et al. Brain alanine formation as an ammonia-scavenging pathway during hyperammonemia: effects of glutamine synthetase inhibition in rats and astrocyte-neuron co- cultures[J]. J Cereb Blood FloW Metab, 2013, 33: 1235-1241.
  • 7Desjardins P, Du T, Jiang W, et al. Pathogenesis of hepatic encephalopathy and brain edema in acute liver failure: role of glutamine redefined[J]. Neurochem Int, 2012, 60: 690-696.
  • 8Albrecht J, Zielifi ska M, Norenberg MD. Glutamine as a mediator of ammonia neurotoxicity: a critical appraisal[J]. Biochem Pharmacol, 2010, 80: 1303-1308.
  • 9Jim6nez B, Montoliu C, Maclntyre DA, et al. Serum metabolic signature of minimal hepatic encephalopathy by (1)H-nuclear magnetic resonance[J]. J Proteome Res, 2010, 9: 5180-5187.
  • 10Rama Rao KV, Norenberg MD. Glutamine in the pathogenesis of hepatic encephalopathy: the trojan horse hypothesis revisited[J]. Neurochem Res, 2013 [Epub ahead of print].

共引文献63

同被引文献34

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部